The C5a Receptor (C5aR) C5L2 Is a Modulator of C5aR-mediated Signal Transduction*
暂无分享,去创建一个
C. Mackay | B. Lu | C. Gerard | N. Gerard | D. Zahra | S. Craig | P. Whitfeld | Hyun Lee | J. Jackson | Claire E. Bamberg | Yun Si Lim | Erin Corsini
[1] R. Lefkowitz,et al. β-arrestin- but not G protein-mediated signaling by the “decoy” receptor CXCR7 , 2009, Proceedings of the National Academy of Sciences.
[2] G. Zaman,et al. C5a-Stimulated Recruitment of β-Arrestin2 to the Nonsignaling 7-Transmembrane Decoy Receptor C5L2 , 2009, Journal of biomolecular screening.
[3] K. Cianflone,et al. C5a- and ASP-mediated C5L2 activation, endocytosis and recycling are lost in S323I-C5L2 mutation. , 2009, Molecular immunology.
[4] P. Monk,et al. The human complement fragment receptor, C5L2, is a recycling decoy receptor , 2009, Molecular immunology.
[5] R. Alon,et al. A crosstalk between intracellular CXCR7 and CXCR4 involved in rapid CXCL12‐triggered integrin activation but not in chemokine‐triggered motility of human T lymphocytes and CD34+ cells , 2008, Journal of leukocyte biology.
[6] Arun K Shukla,et al. Distinct conformational changes in β-arrestin report biased agonism at seven-transmembrane receptors , 2008, Proceedings of the National Academy of Sciences.
[7] C. Mackay,et al. Functional roles for C5a receptors in sepsis , 2008, Nature Medicine.
[8] C. Mackay,et al. Receptors for complement C5a. The importance of C5aR and the enigmatic role of C5L2 , 2008, Immunology and cell biology.
[9] K. Cianflone,et al. Acylation-stimulating protein/C5L2-neutralizing antibodies alter triglyceride metabolism in vitro and in vivo. , 2007, American journal of physiology. Endocrinology and metabolism.
[10] P. Monk,et al. Function, structure and therapeutic potential of complement C5a receptors , 2007, British journal of pharmacology.
[11] Richard P. Harvey,et al. Disrupted cardiac development but normal hematopoiesis in mice deficient in the second CXCL12/SDF-1 receptor, CXCR7 , 2007, Proceedings of the National Academy of Sciences.
[12] K. Cianflone,et al. Reduced adipose tissue triglyceride synthesis and increased muscle fatty acid oxidation in C5L2 knockout mice. , 2007, The Journal of endocrinology.
[13] C. McKerlie,et al. C5L2 is critical for the biological activities of the anaphylatoxins C5a and C3a , 2007, Nature.
[14] P. Monk,et al. Ligand Specificity of the Anaphylatoxin C5L2 Receptor and Its Regulation on Myeloid and Epithelial Cell Lines* , 2006, Journal of Biological Chemistry.
[15] A. Rot,et al. Throwing light on DARC. , 2006, Biochemical Society transactions.
[16] G. Dohm,et al. Lipid metabolism, exercise and insulin action. , 2006, Essays in biochemistry.
[17] K. Cianflone,et al. Effects of fatty acid regulation on visfatin gene expression in adipocytes. , 2006, Chinese medical journal.
[18] L. Kuller,et al. Anthropometry and Breast Cancer Risk in Nigerian Women , 2006, The breast journal.
[19] M. Febbraio,et al. AMP-activated protein kinase--the fat controller of the energy railroad. , 2006, Canadian journal of physiology and pharmacology.
[20] G. Graham,et al. Chemokine scavenging by D6: a movable feast? , 2006, Trends in immunology.
[21] U. Smith,et al. Increased levels of acylation-stimulating protein in interleukin-6-deficient (IL-6(-/-)) mice. , 2006, Endocrinology.
[22] G. Bray,et al. Obesity and Cardiovascular Disease: Pathophysiology, Evaluation, and Effect of Weight Loss , 2006, Arteriosclerosis, thrombosis, and vascular biology.
[23] K. Cianflone,et al. Targeting the signaling pathway of acylation stimulating protein Published, JLR Papers in Press, December 6, 2005. , 2006, Journal of Lipid Research.
[24] Jacqueline Capeau,et al. Recent advances in the relationship between obesity, inflammation, and insulin resistance. , 2006, European cytokine network.
[25] J. Després,et al. Is visceral obesity the cause of the metabolic syndrome? , 2006, Annals of medicine.
[26] Pixu Liu,et al. An Anti-inflammatory Function for the Complement Anaphylatoxin C5a-binding Protein, C5L2* , 2005, Journal of Biological Chemistry.
[27] M. Oppermann,et al. G Protein-coupled Receptor Kinases Promote Phosphorylation and β-Arrestin-mediated Internalization of CCR5 Homo- and Hetero-oligomers* , 2005, Journal of Biological Chemistry.
[28] P. Monk,et al. C5L2 Is a Functional Receptor for Acylation-stimulating Protein* , 2005, Journal of Biological Chemistry.
[29] S. Tomlins,et al. Evidence for a functional role of the second C5a receptor C5L2 , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[30] X. Formiguera,et al. Obesity: epidemiology and clinical aspects. , 2004, Best practice & research. Clinical gastroenterology.
[31] R. Lefkowitz. Historical review: a brief history and personal retrospective of seven-transmembrane receptors. , 2004, Trends in pharmacological sciences.
[32] A. Tzafriri,et al. Analysis of compartmental models of ligand-induced endocytosis. , 2004, Journal of theoretical biology.
[33] M. Faraj,et al. Differential regulation of fatty acid trapping in mouse adipose tissue and muscle by ASP. , 2004, American journal of physiology. Endocrinology and metabolism.
[34] M. Steinmetz,et al. Malonyl-CoA decarboxylase (MCD) is differentially regulated in subcellular compartments by 5'AMP-activated protein kinase (AMPK). Studies using H9c2 cells overexpressing MCD and AMPK by adenoviral gene transfer technique. , 2004, European journal of biochemistry.
[35] R. Nibbs,et al. The chemokine receptor D6 constitutively traffics to and from the cell surface to internalize and degrade chemokines. , 2004, Molecular biology of the cell.
[36] K. Cianflone,et al. ASP enhances in situ lipoprotein lipase activity by increasing fatty acid trapping in adipocytes Published, JLR Papers in Press, January 1, 2004. DOI 10.1194/jlr.M300299-JLR200 , 2004, Journal of Lipid Research.
[37] K. Cianflone,et al. Acylation-stimulating Protein (ASP)/Complement C3adesArg Deficiency Results in Increased Energy Expenditure in Mice* , 2004, Journal of Biological Chemistry.
[38] V. Videm,et al. Changes in Neutrophil Surface‐Receptor Expression After Stimulation with FMLP, Endotoxin, Interleukin‐8 and Activated Complement Compared to Degranulation , 2004, Scandinavian journal of immunology.
[39] J. Després,et al. Fasting acylation-stimulating protein is predictive of postprandial triglyceride clearance Published, JLR Papers in Press, October 16, 2003. DOI 10.1194/jlr.M300214-JLR200 , 2004, Journal of Lipid Research.
[40] J. Krause,et al. C5L2, a nonsignaling C5A binding protein. , 2003, Biochemistry.
[41] K. Cianflone. Acylation stimulating protein and triacylglycerol synthesis: potential drug targets? , 2003, Current pharmaceutical design.
[42] P. Monk,et al. The Chemoattractant Receptor-like Protein C5L2 Binds the C3a des-Arg77/Acylation-stimulating Protein* , 2003, The Journal of Biological Chemistry.
[43] K. Cianflone,et al. Critical review of acylation-stimulating protein physiology in humans and rodents. , 2003, Biochimica et biophysica acta.
[44] Elaine C Meng,et al. Constitutive Activation and Endocytosis of the Complement Factor 5a Receptor: Evidence for Multiple Activated Conformations of a G Protein‐Coupled Receptor , 2002, Traffic.
[45] K. Cianflone,et al. Acylation-stimulating Protein (ASP) Deficiency Induces Obesity Resistance and Increased Energy Expenditure in ob/obMice* , 2002, The Journal of Biological Chemistry.
[46] John D Lambris,et al. Increased C5a receptor expression in sepsis. , 2002, The Journal of clinical investigation.
[47] P. Monk,et al. The Orphan Receptor C5L2 Has High Affinity Binding Sites for Complement Fragments C5a and C5a des-Arg74 * , 2002, The Journal of Biological Chemistry.
[48] Ralph Weissleder,et al. Arthritis critically dependent on innate immune system players. , 2002, Immunity.
[49] B. Jaber,et al. C5a delays apoptosis of human neutrophils by a phosphatidylinositol 3-kinase-signaling pathway. , 2002, Kidney international.
[50] H. Koistinen,et al. Plasma Acylation Stimulating Protein Concentration and Subcutaneous Adipose Tissue C3 mRNA Expression in Nondiabetic and Type 2 Diabetic Men , 2001, Arteriosclerosis, thrombosis, and vascular biology.
[51] N. Bunnett,et al. The proliferative and antiapoptotic effects of substance P are facilitated by formation of a beta -arrestin-dependent scaffolding complex. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[52] A. Beck‐Sickinger,et al. Characterisation of G-protein-coupled receptors by antibodies. , 2000, Current medicinal chemistry.
[53] D. Taub,et al. Early Local Generation of C5a Initiates the Elicitation of Contact Sensitivity by Leading to Early T Cell Recruitment1 , 2000, The Journal of Immunology.
[54] M. Enomoto,et al. A putative chemoattractant receptor, C5L2, is expressed in granulocyte and immature dendritic cells, but not in mature dendritic cells. , 2000, Molecular immunology.
[55] R. Lefkowitz,et al. β-Arrestin1 Interacts with the Catalytic Domain of the Tyrosine Kinase c-SRC , 2000, The Journal of Biological Chemistry.
[56] P. Havel,et al. Acylation Stimulating Protein (ASP) Deficiency Alters Postprandial and Adipose Tissue Metabolism in Male Mice* , 1999, The Journal of Biological Chemistry.
[57] K. Cianflone,et al. Enhanced triglyceride clearance with intraperitoneal human acylation stimulating protein in C57BL/6 mice. , 1999, American journal of physiology. Endocrinology and metabolism.
[58] Vu,et al. Plasma acylation stimulating protein, adipsin and lipids in non‐obese and obese populations , 1999, European journal of clinical investigation.
[59] S. Reynisdottir,et al. Mechanisms Involved in the Regulation of Free Fatty Acid Release from Isolated Human Fat Cells by Acylation-stimulating Protein and Insulin* , 1999, The Journal of Biological Chemistry.
[60] Y. Deshaies,et al. Response of adipose tissue lipoprotein lipase to the cephalic phase of insulin secretion. , 1999, Diabetes.
[61] K. Cianflone,et al. Acylation stimulating protein (ASP), an adipocyte autocrine: new directions. , 1999, Seminars in cell & developmental biology.
[62] M. Caron,et al. Beta-arrestin-dependent formation of beta2 adrenergic receptor-Src protein kinase complexes. , 1999, Science.
[63] M. Maslowska,et al. Chylomicron-specific Enhancement of Acylation Stimulating Protein and Precursor Protein C3 Production in Differentiated Human Adipocytes* , 1998, The Journal of Biological Chemistry.
[64] K. Cianflone,et al. Coordinated release of acylation stimulating protein (ASP) and triacylglycerol clearance by human adipose tissue in vivo in the postprandial period. , 1998, Journal of lipid research.
[65] U. Höpken,et al. Impaired Inflammatory Responses in the Reverse Arthus Reaction Through Genetic Deletion of the C5a Receptor , 1997, The Journal of experimental medicine.
[66] M. Delp,et al. Physiological Parameter Values for Physiologically Based Pharmacokinetic Models , 1997, Toxicology and industrial health.
[67] K. Cianflone,et al. ASP stimulates glucose transport in cultured human adipocytes , 1997, International Journal of Obesity.
[68] R. Zechner,et al. The tissue-specific expression of lipoprotein lipase: implications for energy and lipoprotein metabolism. , 1997, Current opinion in lipidology.
[69] K. Cianflone,et al. Acylation-stimulating protein (ASP) regulates glucose transport in the rat L6 muscle cell line. , 1997, Biochimica et biophysica acta.
[70] B. Spiegelman,et al. Regulation of alternative pathway activation and C3a production by adipose cells. , 1996, Obesity research.
[71] K. Cianflone,et al. Differentiation‐induced production of ASP in human adipocytes , 1995, European journal of clinical investigation.
[72] R. Gougeon,et al. Response of plasma ASP to a prolonged fast. , 1995, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity.
[73] R. Eckel,et al. Alterations in lipoprotein lipase in insulin resistance. , 1995, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity.
[74] G. Johnson,et al. Mapping of the C5a receptor signal transduction network in human neutrophils. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[75] L. Pitts,et al. Fluid‐phase endocytosis of horseradish peroxidase by cerebral endothelial cells in primary culture: Characterization and kinetic analysis , 1994, Journal of neuroscience research.
[76] K. Cianflone,et al. Coordinate regulation of triacylglycerol synthesis and glucose transport by acylation-stimulating protein. , 1993, Metabolism: clinical and experimental.
[77] T. Møller-Pedersen,et al. Lipoprotein lipase activity in muscle tissue influenced by fatness, fat distribution and insulin in obese females , 1993, European journal of clinical investigation.
[78] R. Eckel,et al. Levels of acylation stimulating protein in obese women before and after moderate weight loss. , 1991, International journal of obesity.
[79] K. Cianflone,et al. The effect of ASP on the adipocyte of the morbidly obese. , 1989, The Journal of surgical research.
[80] J. Gallin,et al. Structural analysis of human neutrophil migration: Centriole, microtubule, and microfilament orientation and function during chemotaxis , 1977, The Journal of cell biology.
[81] A. Klos,et al. C5L2--an anti-inflammatory molecule or a receptor for acylation stimulating protein (C3a-desArg)? , 2007, Advances in experimental medicine and biology.
[82] A. Russell. Lipotoxicity: the obese and endurance-trained paradox , 2004, International Journal of Obesity.
[83] C. Gerard,et al. C5A anaphylatoxin and its seven transmembrane-segment receptor. , 1994, Annual review of immunology.
[84] P. Nilsson-ehle,et al. Impaired regulation of adipose tissue lipoprotein lipase in obesity. , 1981, International journal of obesity.
[85] K. Cianflone,et al. Printed in U.S.A. Copyright © 2000 by The Endocrine Society Reduced Body Weight, Adipose Tissue, and Leptin Levels Despite Increased Energy Intake in Female Mice Lacking Acylation-Stimulating Protein* , 2022 .